Risk-treatment paradox in women with symptomatic coronary artery disease

Clinical Research in Cardiology Supplements

Volumn 8, Issue SUPPL. 1, 2013, Pages 20-24

  Mehilli, Julinda ^a   King, Lamin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Coronary intervention; Myocardial infarction; Sex; Stent; Women

Indexed keywords

ABCIXIMAB; CLOPIDOGREL; EVEROLIMUS; GLYCOPROTEIN P INHIBITOR; HEPARIN; HIRULOG; PLACEBO; PURINERGIC P2Y12 RECEPTOR;

ARTICLE; BLEEDING; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR RISK; COMORBIDITY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; EVIDENCE BASED PRACTICE; HUMAN; INCIDENCE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION; RESTENOSIS; REVASCULARIZATION; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84875522417     PISSN: 18610706     EISSN: 18610714     Source Type: Journal    
DOI: 10.1007/s11789-013-0052-3     Document Type: Article

References (44)

1. Alexander KP, Chen AY, Newby LK et al (2006) Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation 114(13): 1380-1387. doi: 10. 1161/CIRCULATIONAHA. 106. 620815.
2. Alexander KP, Newby LK, Armstrong PW et al (2007) Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 115(19): 2570-2589. doi: 10. 1161/CIRCULATIONAHA. 107. 182616.
3. Al-Fiadh AH, Andrianopoulos N, Farouque O et al (2011) Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes. Int J Cardiol 151(2): 195-199. doi: 10. 1016/j. ijcard. 2010. 05. 018.
4. Alfredsson J, Stenestrand U, Wallentin L et al (2007) Gender differences in management and outcome in non-ST-elevation acute coronary syndrome. Heart 93(11): 1357-1362. doi: 10. 1136/hrt. 2006. 102012.
5. Alfredsson J, Lindback J, Wallentin L et al (2011) Similar outcome with an invasive strategy in men and women with non-ST-elevation acute coronary syndromes: from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Eur Heart J 32(24): 3128-3136. doi: 10. 1093/eurheartj/ehr349.
6. Anderson RD, Pepine CJ (2007) Gender differences in the treatment for acute myocardial infarction: bias or biology? Circulation 115(7): 823-826. doi: 10. 1161/CIRCULATIONAHA. 106. 685859.
7. Berger JS, Elliott L, Gallup D et al (2009) Sex differences in mortality following acute coronary syndromes. JAMA 302(8): 874-882. doi: 10. 1001/jama. 2009. 1227.
8. Blomkalns AL, Chen AY, Hochman JS et al (2005) Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 45(6): 832-837. doi: 10. 1016/j. jacc. 2004. 11. 055.
9. Boersma E, Harrington RA, Moliterno DJ et al (2002) Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 359(9302): 189-198.
10. Daly C, Clemens F, Lopez-Sendon JL et al (2006) The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina. Eur Heart J 27(11): 1298-1304. doi: 10. 1093/eurheartj/ehl005.
11. Dey S, Flather MD, Devlin G et al (2009) Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart 95(1): 20-26. doi: 10. 1136/hrt. 2007. 138537.
12. Diercks DB, Owen KP, Kontos MC et al (2010) Gender differences in time to presentation for myocardial infarction before and after a national women's cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG). Am Heart J 160(1): 80-87 e83. doi: 10. 1016/j. ahj. 2010. 04. 017.
13. Dorsam RT, Kunapuli SP (2004) Central role of the P2Y12 receptor in platelet activation. The Journal of clinical investigation 113(3): 340-345. doi: 10. 1172/JCI20986.
14. Glaser R, Herrmann HC, Murphy SA et al (2002) Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA 288(24): 3124-3129.
15. Gulati M, Cooper-DeHoff RM, McClure C et al (2009) Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med 169(9): 843-850. doi: 10. 1001/archinternmed. 2009. 50.
16. Hannan EL, Racz MJ, Arani DT et al (2000) A comparison of short- and long-term outcomes for balloon angioplasty and coronary stent placement. J Am Coll Cardiol 36(2): 395-403.
17. Herlitz J, Dellborg M, Karlsson T et al (2009) Treatment and outcome in acute myocardial infarction in a community in relation to gender. Int J Cardiol 135(3): 315-322. doi: 10. 1016/j. ijcard. 2008. 03. 065.
18. Hochholzer W, Wiviott SD, Antman EM et al (2011) Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38). Circulation 123(23): 2681-2689. doi: 10. 1161/CIRCULATIONAHA. 110. 002683.
19. Kaseta JR, Skafar DF, Ram JL et al (1999) Cardiovascular disease in the diabetic woman. J Clin Endocrinol Metab 84(6): 1835-1838.
20. Kastrati A, Neumann FJ, Schulz S et al (2011) Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. N Engl J Med 365(21): 1980-1989. doi: 10. 1056/NEJMoa1109596.
21. Kumbhani DJ, Shishehbor MH, Willis JM et al (2012) Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention. Am J Cardiol 109(8): 1087-1091. doi: 10. 1016/j. amjcard. 2011. 11. 044.
22. Lansky AJ, Costa RA, Mooney M et al (2005) Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. J Am Coll Cardiol 45(8): 1180-1185. doi: 10. 1016/j. jacc. 2004. 10. 076.
23. Lansky AJ, Hochman JS, Ward PA et al (2005) Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation 111(7): 940-953. doi: 10. 1161/01. CIR. 0000155337. 50423. C9.
24. Lansky AJ, Mehran R, Cristea E et al (2009) Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial). Am J Cardiol 103(9): 1196-1203. doi: 10. 1016/j. amjcard. 2009. 01. 030.
25. McAlister FA, Oreopoulos A, Norris CM et al (2007) Exploring the treatment-risk paradox in coronary disease. Arch Intern Med 167(10): 1019-1025. doi: 10. 1001/archinte. 167. 10. 1019.
26. Mehilli J, Kastrati A, Dirschinger J et al (2000) Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA 284(14): 1799-1805.
27. Mehilli J, Kastrati A, Dirschinger J et al (2002) Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. JAMA 287(2): 210-215.
28. Mehilli J, Kastrati A, Bollwein H et al (2003) Gender and restenosis after coronary artery stenting. Eur Heart J 24(16): 1523-1530.
29. Mehilli J, Ndrepepa G, Kastrati A et al (2005) Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction. J Am Coll Cardiol 45(6): 828-831. doi: 10. 1016/j. jacc. 2004. 11. 054.
30. Mehilli J, Ndrepepa G, Kastrati A et al (2007) Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial. Am Heart J 154(1): 158 e151-157. doi: 10. 1016/j. ahj. 2007. 03. 050.
31. Mehilli J, Kastrati A, Schulz S et al (2009) Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation 119(14): 1933-1940. doi: 10. 1161/CIRCULATIONAHA. 108. 818617.
32. Miettinen H, Lehto S, Salomaa V et al (1998) Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 21(1): 69-75.
33. Min JK, Dunning A, Lin FY et al (2011) Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23, 854 patients without known coronary artery disease. J Am Coll Cardiol 58(8): 849-860. doi: 10. 1016/j. jacc. 2011. 02. 074.
34. Mosca L, Linfante AH, Benjamin EJ et al (2005) National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 111(4): 499-510. doi: 10. 1161/01. CIR. 0000154568. 43333. 82.
35. Ng VG, Lansky AJ, Hermiller JB et al (2011) Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial). Am J Cardiol 107(6): 841-848. doi: 10. 1016/j. amjcard. 2010. 10. 068.
36. Roger VL, Go AS, Lloyd-Jones DM et al (2012) Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125(1): e2-e220. doi: 10. 1161/CIR. 0b013e31823ac046.
37. Schulz S, Birkmeier KA, Ndrepepa G et al (2010) One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial. Clinical research in cardiology: official journal of the German Cardiac Society 99(12): 795-802. doi: 10. 1007/s00392-010-0185-z.
38. Stefanini GG, Kalesan B, Pilgrim T et al (2012) Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. JACC Cardiovasc Interv 5(3): 301-310. doi: 10. 1016/j. jcin. 2011. 11. 011.
39. Stone GW, McLaurin BT, Cox DA et al (2006) Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355(21): 2203-2216. doi: 10. 1056/NEJMoa062437.
40. Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11): 1045-1057. doi: 10. 1056/NEJMoa0904327.
41. Wiviott SD, Cannon CP, Morrow DA et al (2004) Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation 109(5): 580-586. doi: 10. 1161/01. CIR. 0000109491. 66226. 26.
42. Wiviott SD, Braunwald E, McCabe CH et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. New Engl J Med 357(20): 2001-2015. doi: 10. 1056/NEJMoa0706482.
43. Yan AT, Yan RT, Tan M et al (2007) Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes. Arch Intern Med 167(10): 1009-1016. doi: 10. 1001/archinte. 167. 10. 1009.
44. Yeh RW, Sidney S, Chandra M et al (2010) Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362(23): 2155-2165. doi: 10. 1056/NEJMoa0908610.